Research Interest: QSAR, Medicinal Chemistry, Organic Synthesis, Cytotoxicity, Heterocyclic Compounds, Synthesis, Synthesis of Organic Molecules, Pharmaceutical Development, Antioxidant Activity, Mutagenicity.

Research Interest: Natural products chemistry (including extraction and separation of compounds and structure elucidation), Discovery and biological investigation of novel drug lead compounds from plant and microbial biodiversity, Botanical dietary supplements and functional foods research and evaluation of natural product-based botanical medicines, Quality control, pharmacokinetics and in vivo metabolism of Traditional Chinese Medicine.

Research Interest: Cardiovascular pharmacology, New Therapeutic targets for atherosclerosis, hypertension and vasculogenesis, Screening of TCM and ethnic drugs.

Research Interest: Experimental and clinical pharmacology about natural product, Pharmacokinetics of  medicinal plant.

Research Interest: Pharmacology & Toxicology, Experimental Pharmacology, Toxicology.

Research Interest: Liposomes, Drug Nanoparticles, Solid Lipid Nanoparticles and Lipid Based Drug Delivery Systems.

Research Interest: Separation & purification and quality control of food science; new functional materials for food and pharmaceutical analysis.

After graduation I started to work at Medical University of Silesia, where I completed my PhD thesis on genetic polymorphisms in coronary artery disease. Selected risk factors for development of arterial ischemic stroke in children were also in the area of my scientific interests. Besides, I am also interested in diagnosis and treatment of other neurological disorders in children: schizencephaly, headache, epilepsy and cerebral palsy. Nine years ago, when I moved to the Department of Pharmaceutical Technology I started the research concerning the technology for the manufacturing and optimization of micro- and nanocarriers of active substances. In addition, I am involved in analyses of rheological parameters of semi-solid preparations.

Research Interest: developmental neurology, neuroscience, genetics, pharmaceutical technology, nanotechnology, biochemistry

Grants: I participated in a multi-center Polish scientific grant and in several academic grants. In 2017, I was a supervisor of a grant of Medical University of Silesia regarding the release of active substances from semi-solid bases.

List of Publications:
Selected articles of my authorship:
1. Beata Sarecka-Hujar, Ilona Kopyta. Poststroke epilepsy: current perspectives on diagnosis and treatment. Neuropsychiatr.Dis.Treat. 2019; Vol.15, p.95-103

2. Joanna Sordyl, Ilona Kopyta, Beata Sarecka-Hujar, Tomasz Francuz, Paweł Matusik, Ewa Małecka-Tendera. Lipid levels and selected biomarkers of vascular changes in children with idiopathic headaches - a preliminary report. Arch.Med.Sci. 2019; Vol.15, No.1, p.120-125

3. Beata Sarecka-Hujar, Andrzej Jankowski, Aneta Ostróżka-Cieślik, Radosław Balwierz, Anna Banyś, Renata Dyja, Dariusz Łukowiec, Dominik Marciniak, Janusz Pluta. Assessment of release of trimetazidine hydrochloride from orally disintegrating tablets (ODTs) prepared using different disintegrants. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.3, p.697-704

4. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar, Tomasz Krzykawski, Jagna Karcz, Anna Banyś, Andrzej Jankowski. Application of selected diffractive and microscopic methods to evaluate the physical state of drug and morphology of microspheres obtained by spray drying of furosemide with Eudragit L30 D-55. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.3, p.759-765

5. Beata Sarecka-Hujar, Ilona Kopyta, Michał Skrzypek. Is the 1298A>C polymorphism in the MTHFR gene a risk factor for arterial ischaemic stroke in children? The results of meta.analysis. Clin.Exp.Med. 2018; Vol.18, No.3, p.337-345. 

6. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar, Andrzej Jankowski. Physicochemical characteristics of furosemide incorporated Eudragit microspheres formulated by spray drying. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.6, p.1369-1376

7. Beata Sarecka-Hujar, Radosław Balwierz, Aneta Ostróżka-Cieślik, Renata Dyja, Dariusz Łukowiec, Andrzej Jankowski. Scanning electron microscopy and X-ray energy dispersive spectroscopy - useful tools in the analysis of pharmaceutical products. J.Phys.: Conf.Series 2017; Vol.931, 012008, p.1-5

8. Andrzej Jankowski, Renata Dyja, Beata Sarecka-Hujar. Dermal and transdermal delivery of active substances from semisolid bases. Indian J.Pharmaceut.Sci. 2017; Vol.79, No.4, p.488-500

9. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar. The use of nanotechnology in modern pharmacotherapy. In: Multifunctional systems for combined delivery, biosensing and diagnostics. / Editors: Alexandru Mihai Grumezescu, Amsterdam: Elsevier Inc., 2017, p. 139-158, ISBN: 978-0-323-52725-5

10. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar. Perspectives of the carbon nanoparticles use in cancer therapy and imaging. Post.Biol.Kom. 2017; T.44, nr 2, s.171-184

11. Dorota Raczkiewicz, Beata Sarecka-Hujar, Alfred Owoc, Iwona Bojar. Cognitive functions and serum cortisol concentration in perimenopausal and postmenopausal women working non-manually. Neuroendocrinol.Lett. 2017; Vol.38, No.4, p.269-274

12. Dorota Raczkiewicz, Alfred Owoc, Beata Sarecka-Hujar, Iwona Bojar. Pain involving the motor system and serum vitamin D concentration in postmenopausal women working in agriculture. Ann.Agric.Environ.Med. 2017; Vol.24, No.1, p.151-155

13. Beata Sarecka-Hujar, Ilona Kopyta, Michał Skrzypek, J. Sordyl. Association between the 20210G>A prothrombin gene polymorphism and arterial ischemic stroke in children and young adults - two meta-analyses of 3586 cases and 6440 control subjects in total. Pediatr.Neurol. 2017; Vol.69, p.93-101

14. Beata Sarecka-Hujar, Aneta Ostróżka-Cieślik, Anna Banyś. Determinants of telemedicine development in health care system. Ann.Acad.Med.Siles. 2016; Vol.70, s.214-219

15. Ilona Kopyta, Paweł Niemiec, Anna Balcerzyk, Ewa Emich-Widera, Ewa Pilarska, Karolina Pienczk-Recławowicz, Marek Kaciński, Janusz Wendorff, Tomasz Nowak, Tomasz Iwanicki, Beata Sarecka-Hujar, Iwona Żak. Fibrinogen alpha and beta gene polymorphisms in pediatric stroke - Case-control and family based study. Eur.J.Paediatr.Neurol.2015; Vol.19, No.2, p.176-180

16. Ilona Kopyta, Mikołaj Zimny, Beata Sarecka-Hujar. The role of biochemical risk factors in the etiology of AIS in children and adults. Int.J.Neurosci.2015; Vol.125, No.12, p.875-884

17. Anna Banyś, Beata Sarecka-Hujar, Andrzej Jankowski, Monika Zalewska. Impact of base type on diclofenac sodium release from semi-solid dosage forms. Ann.Acad.Med.Siles. 2014; Vol.68, No.1, s.1-8

18. Ilona Kopyta, Beata Sarecka-Hujar, Joanna Sordyl, Ryszard Sordyl. The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review. Mol.Biol.Rep. 2014; Vol.41, No.7, p.4241-4251

19. Beata Sarecka-Hujar, Iwona Żak, Ewa Emich-Widera et al. Association analysis of the E-selectin 98G>T polymorphism and the risk of childhood ischemic stroke. Cell Biochem. Funct. 2010; 28: 591-596.

20. Ilona Kopyta, Beata Sarecka-Hujar, Ewa Emich-Widera et al. Association between lipids and fibrinogen levels and ischemic stroke in the population of the Polish children with arteriopathy and cardiac disorders. Wiad. Lek. 2010; 63:17-23.  

21. Zak I, Sarecka-Hujar B, Kopyta I et al. The T allele of the 677C>T polymorphism of methylenetetrahydrofolate reductase gene is associated with an increased risk of ischemic stroke in Polish children. J Child Neurol. 2009; 24: 1262-1267. 

22. Sarecka-Hujar B, Zak I, Krauze J. Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors influence susceptibility to coronary artery disease. Clin Exp Med. 2009; 9: 117-124.

Research Interest: Organic & Biomolecular Chemistry, Department of Pharmacy.

Dr. Chavda is dedicated and highly motivated research scientist with more than 13 years of rich Industry-Academic experience. His area of interest is development of formulations including Oral solids, Liquids, Semi-solids, Parenterals and NDDS. He has developed stable and robust formulations across various dosage forms. He has sound understanding of formulation and development using QbD and DOE approaches. He has understanding of product development lifecycle, clinical and regulatory requirements of regulatory bodies like UKMHRA, USFDA etc. There are more than 35 International and National research publications to his credit. In addition to that he has several magazines related articles and Books publications. He is providing editorial service for international journals. He is serving as reviewer at Elsevier, Bentham Sciences, Informa Healthcare, and Wiley Journals.

Research Interest:

Pharmaceutics and Pharmaceutical Technology, with a focus on Formulation Development, Technology Transfer, Pharmaceutical Process Optimization, Scale-Up and Validation, Documentation Systems, Manufacturing Troubleshooting, Pharmaceutical Tools, and Digital Pharmaceutical Solutions. Research and professional interests also include Pharmaceutical Product Development for regulated and semi-regulated markets across Solid Oral Dosage Forms, Oral Liquids, Parenterals, Semisolids, and Novel Drug Delivery Systems.

Orcid ID

https://orcid.org/0000-0001-8821-7578

List of publications:

1. Chavda HV*, Neerumalla S, Patel A, Poptani S. Excipients: The Real Players behind Robust

Formulation. Indian Journal of Pharmaceutical Education and Research. January 2019; 53(1):

5-7.

2. Chavda HV*. Artificial Neural Networks in Pharma Product Development. Chronicle

Pharmabiz. May 2018; 18(23): 42-43.

3. Chavda HV*. 3D printing: Upcoming revolution for pharmaceutical industry. Chronicle

Pharmabiz. April 2018; 18(21): 10.

4. Chavda HV*. Qbd in Developing Topical Dosage Forms. Elyns Journal of Pharmaceutical

Research December 2016; 2(1): 90000106. [Short Communication]

5. Chavda HV*. Nanopharmaceuticals: The Pharmaceuticals of Present Era. Elyns Journal of

Pharmaceutical Research 2016; 1(2): 106e. [Editorial Article]

6. Chavda HV*, Naik S, Mukhopadhyay P. QbD Concept Implementation for Excipients.

Ingredients South Asia Magazine. Saffron Media Publication, November, 2016; 11: 119-120.

7. Chavda HV*. Reforms in Pharmaceutical Education in India. Ingredients South Asia

Magazine. Saffron Media Publication, April 16-30, 2016; 9(14): 48-51.

8. Chavda HV*. African Market: Big Window of Opportunity. Ingredients South Asia Magazine.

Saffron Media Publication, January 16-31, 2016; 9(8): 30-32.

9. Chavda HV*. SPHs as an Unusual Upcoming Excipient. Ingredients South Asia Magazine.

Saffron Media Publication, December 1-15, 2015; 9(5): 104-111.

10. Chavda HV*, Patel RI, Patel CN. Preparation and Characterization of Ternary Solid Dispersion

of Flunarizine Dihydrochloride. World Journal of Pharmaceutical Research (ISSN: 2277-7105)

2015; 4(5): 2506-2521.

11. Chavda HV*, Chavada G, Patel J, Rangpadiya K, Patel CN. Topical Vaginal Drug Delivery

System Based on Superporous Hydrogel Hybrids. Protein & Peptide Letters (ISSN: 0929-8665,

Impact Factor 1.735) 2014; 21(11): 1176-1184.

12. Chavda HV*, Patel RD, Modhia IP, Patel CN. Role of Superporous Hydrogel Particles as a

Superdisintegrant in Fast Disintegrating Tablet of Glipizide. Chronicles of Young Scientists

(ISSN: 2229-5186) 2014; 5(1):11-19.

13. Chavda HV*, Patel J, Chavada G, Dave S, Patel A, Patel CN. Self Nanoemulsifying Powder of

Isotretinoin: Preparation and Characterization. Journal of Powder Technology. (ISSN: 2090-

7737) 2013; 2013 Article ID 108569, 9 pages. [Cited on 15/11/2013].

14. Chavda HV*, Modhia IP, Mehta A, Patel RD, Patel CN. Development of Bioadhesive Chitosan

Superporous Hydrogel Composite Particles based Intestinal Drug Delivery System. BioMed

Research International (ISSN: 2314-6133, Impact Factor 2.880) 2013; 2013 Article ID 563651,

10 pages. [Cited on 06/08/2013]

Page 7 of 12 Dr. Hitesh Chavda

15. Chavda HV*, Patel SK, Patel CN. Insignificant Effect of Superporous Hydrogel Particles as a

Superdisintegrants in Fast Dispersible Tablets of Aceclofenac. Online article PharmaTutor

(ISSN: 2347 - 7881) 2013 (Published on Web 31/01/2013). Available from:

http://www.pharmatutor.org/articles/ insignificant-effect-of-superporous-hydrogelparticles-

as-superdisintegrants-in-fast-dispersible-tablets-of-aceclofenac?page=0,0 [Cited on

31/01/2013].

16. Chavda HV*, Patel RD, Modhia IP, Patel CN. Preparation and Characterization of

Superporous Hydrogel Based on Different Polymers. Int J Pharm Investig (ISSN: 2230-973X)

2012; 2(3):134-139.

17. Chavda HV*, Patel MS, Patel CN. Preparation and In Vitro Evaluation of Guar Gum Based

Triple-Layer Matrix Tablet of Diclofenac Sodium. Res Pharm Sci (ISSN: 1735-5362, Impact

Factor 0.220) 2012; 7(1): 57-64.

18. Chavda HV*, Patel CN. Pharmaceutical Formulations for Oral Transmucosal Drug Delivery.

News Tech 2011; 29:10-11.

19. Chavda HV*, Patel CN, Modh KM, Panigrahi B. Preparation, Characterization and In Vitro

Evaluation of Carbopol-based Superporous Hydrogel Composite. Indian J Pharm Sci (ISSN:

0250-474X, Impact Factor: 0.626) 2011; [Accepted on 12/05/2011].

20. Chavda HV*, Chaudhari TM, Patel CN. Antacids Incorporation in Immediate Release Tablets

Failed to Improve the Stability of Omeprazole in Acidic Media. J Pharm Negative Results

(ISSN: 0976-9234) 2011; 2(2):73-77.

21. Chavda HV*, Patel CN. Preparation and in vitro evaluation of a stomach specific drug delivery

system based on superporous hydrogel composite. Indian J Pharm Sci (ISSN: 0250-474X,

Impact Factor: 0.626) 2011; 73(1):30-37.

22. Chavda HV*, Patel CN. Effect of Crosslinker Concentration on Characteristics of Superporous

Hydrogel. Int J Pharm Investig (ISSN: 2230-973X) 2011; 1(1):17-21.

23. Chavda HV*, Patel CN. A Newer Formulation Approach: Superporous Hydrogel Composite-

Based Bioadhesive Drug-Delivery System. Asian J Pharm Sci (ISSN: 1818-0876, Impact Factor

0.250) 2010; 5(6): 239-250.

24. Chavda HV*, Patel CN. Chitosan Superporous Hydrogel Composite-Based Floating Drug-

Delivery System: A Newer Formulation Approach. J Pharm Bioall Sci (ISSN: 0976-4879,

Impact Factor 0.175) 2010; 2(2): 124-131.

25. Chavda HV*, Patel CN, Prajapati ST, Patel CV. A Newer Formulation Approach Based on

Superporous Hydrogel Particles for Gastroretentive Drug-Delivery System: Preparation and

In Vitro Evaluation. Inventi Impact: NDDS (ISSN: 2229-4147) 2010; 2: Article ID: 2010nd70a

(Published on Web 15/07/2010; www.inventi.in).

26. Chavda HV*, Patel CN, Prajapati ST, Patel CV. A Newer Formulation Approach Based on

Superporous Hydrogel Particles for Gastroretentive Drug-Delivery System: Preparation and

In Vitro Evaluation. Inventi Rapid: NDDS (e-ISSN: 0976-3791) 2010; 1(1): Article ID:

2010nd70a (Published on Web 13/04/2010; www.inventi.in).

27. Chavda HV*, Patel CN, Anand IS. Biopharmaceutics Classification System. Syst Rev Pharm

(ISSN: 0975-8453) 2010; 1(1): 62-69.

28. Chavda HV*, Patel CN. Preparation and Characterization of Swellable Polymer-based

Superporous Hydrogel Composite of Poly (Acrylamide-co-Acrylic Acid). Trends Biomater Artif

Organs (ISSN: 0971-1198, Impact Factor: 0.675) 2010; 24(2): 83-89.

29. Chavda HV*, Patel CN. Effects of Solvent Treatments on Characteristics of Superporous

Hydrogels. Ethiopian Pharm J (ISSN: 1029-5933) 2009; 27(1): 16-24.

30. Chavda HV*, Patel CN, Karen HD. Preparation and Characterization of Chitosan-Based

Superporous Hydrogel Composite. J Young Pharm (ISSN: 0975-1483) 2009; 1(3): 199-204.

31. Chavda HV*, Patel CN. Aquaporins: Secret Highways for Water Transport. Pharm Reviews

(ISSN: 1918-5561) 6(2), Apr 11, 2008.

Page 8 of 12 Dr. Hitesh Chavda

32. Chavda HV*, Patel CN, Patel AM, Patel BN. Supercritical Fluid: Green Solvent for Tomorrow.

Pharm Reviews (ISSN: 1918-5561)5(3), May 16, 2007.

33. Chavda HV*. Dendrimers: Polymers of 21st Century. Pharm Reviews (ISSN: 1918-5561) 5(1),

Feb. 02, 2007.

Co-author:

34. Modi J*, Patel JK, Chavda HV. Superporous Hydrogel: A Supreme Approach for Gastric

Retention. Online article PharmaTutor (ISSN: 2347 - 7881) 2012 (Published on Web

03/08/2012). Available from: http://www.pharmatutor.org/articles/superporous-hydrogela-

supreme-approach-for-gastric-retention [Cited on 31/01/2013].

35. Karen HD*, Anand IS, Patel CN, Chavda HV, Patel JK. Formulation and Evaluation of

Amphotericin-B as A Lyophilized Product. J Global Pharma Tech (ISSN: 0975-8542) 2010;

2(2): 75-78.

36. Parikh BN*, Gothi GD, Patel TD, Chavda HV, Patel CN. Microsponge as Novel Topical Drug

Delivery System. J Global Pharma Tech (ISSN: 0975-8542) 2010; 2(1): 17-29.

Research Interest: Systems Pharmacology, Drug Metabolism & Drug Transport, Pharmacokinetics/Pharmacometrics, Pharmacogenomics, Nanomedicine and Chinese Medicine.

Research Interest: Natural drug discovery, Isolation, Physiological and pharmacological characterization of venom/toxin peptides and proteinswith animal tissues, Natural peptides and proteins analytical Chemistry, Mass spectrometry analysis, Molecular biology, Synthetic peptide analogues and their interaction with antibodies and receptors, Identification of novel drug targets, Biomarkers, Ion channel.

Research Interest: Medicinal Plants, Obtaining, Characterization and standardization of extracts, Testing their pharmacological Action, Testing antioxidant activity in vitro and in vivo, Analysis and  isolation of biologically active compounds (polyphenols, carotenoides, essential oils, terpenes, alkaloids), spectrometric and chromatographical analysis (HPLC, GC).

Research Interest: Expression Microarrays, Next Generation Sequencin, Liquid Handling Robotics, cDNA Synthesis, RNA Isolation, Splicing, PCR, Gene Expressio, Cell Cultur, Molecular Cloning, Regulation of Gene Expression, RNA Biology, Transcriptomics, Gel Electrophoresis, RNA Splicing.